Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study
28 August 2023 (13:15 - 14:00)
Organised by: 
About the speaker
University of Pisa, Pisa (Italy)
7 More presentations in this session
Doctor E. Kongebro (Copenhagen, DK)
Doctor J. Song (Los Angeles, US)
Doctor J. Jaakkola (Turku, FI)
Assistant Professor I. Kim (Seoul, KR)
Associate Professor M. Proietti (Milan, IT)
Access the full session
The Event
ESC Congress 2023
28 August 2023
13:15 CET
You may be interested in
Congress Presentation
